{
    "id": 7497,
    "name": "brain ependymoma",
    "source": "DOID",
    "definition": "A brain glioma that is characterized by tumor of the ependyma, has_material_basis_in abnormally proliferating cells derives_from ependymal cells, located_in spine in adults and located_in intracranial (4th ventricle) in children. [url:https\\://en.wikipedia.org/wiki/Ependyma, url:https\\://en.wikipedia.org/wiki/Ependymoma]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:7497",
    "evidence": [
        {
            "id": 17683,
            "approvalStatus": "Guideline",
            "evidenceType": "Prognostic",
            "efficacyEvidence": "RELA fusions are associated with more aggressive forms of ependymoma (NCCN.org).",
            "molecularProfile": {
                "id": 29414,
                "profileName": "RELA fusion"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 7497,
                "name": "brain ependymoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        },
        {
            "id": 17690,
            "approvalStatus": "Guideline",
            "evidenceType": "Prognostic",
            "efficacyEvidence": "C11orf95-RELA fusions are associated with more aggressive forms of ependymoma (NCCN.org).",
            "molecularProfile": {
                "id": 32742,
                "profileName": "C11orf95 - RELA"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 7497,
                "name": "brain ependymoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT01096368",
            "title": "Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma",
            "phase": "Phase III",
            "recruitment": "Active, not recruiting",
            "therapies": [
                {
                    "id": 8074,
                    "therapyName": "Carboplatin + Cyclophosphamide + Vincristine sulfate liposome",
                    "synonyms": null
                },
                {
                    "id": 8073,
                    "therapyName": "Carboplatin + Etoposide + Vincristine sulfate liposome",
                    "synonyms": null
                },
                {
                    "id": 8076,
                    "therapyName": "Cisplatin + Cyclophosphamide + Etoposide",
                    "synonyms": null
                },
                {
                    "id": 8075,
                    "therapyName": "Cisplatin + Cyclophosphamide + Etoposide + Vincristine sulfate liposome",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT01295944",
            "title": "Carboplatin and Bevacizumab for Recurrent Ependymoma",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 2074,
                    "therapyName": "Bevacizumab + Carboplatin",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT02458339",
            "title": "Methotrexate Infusion Into Fourth Ventricle in Children With Recurrent Malignant Fourth Ventricular Brain Tumors",
            "phase": "Phase I",
            "recruitment": "Completed",
            "therapies": [
                {
                    "id": 1639,
                    "therapyName": "Methotrexate",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03434262",
            "title": "Molecularly-Driven Doublet Therapy for Recurrent CNS Malignant Neoplasms",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 6688,
                    "therapyName": "Filgrastim + Gemcitabine + Pegfilgrastim + Ribociclib",
                    "synonyms": null
                },
                {
                    "id": 2,
                    "therapyName": "Trametinib",
                    "synonyms": null
                },
                {
                    "id": 1428,
                    "therapyName": "Sonidegib",
                    "synonyms": null
                },
                {
                    "id": 790,
                    "therapyName": "Ribociclib",
                    "synonyms": null
                },
                {
                    "id": 4472,
                    "therapyName": "Ribociclib + Trametinib",
                    "synonyms": null
                },
                {
                    "id": 6687,
                    "therapyName": "Ribociclib + Sonidegib",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03698994",
            "title": "Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 997,
                    "therapyName": "Ulixertinib",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03727841",
            "title": "Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 2143,
                    "therapyName": "Marizomib",
                    "synonyms": null
                }
            ]
        }
    ]
}